Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Sep 19, 2026 Sep 18, 2026 Sep 17, 2026 Sep 16, 2026 Sep 14, 2026 Sep 13, 2026 Sep 12, 2026 Sep 11, 2026 Sep 10, 2026 Sep 9, 2026 Sep 8, 2026 Sep 5, 2026 Sep 4, 2026 Sep 3, 2026 Sep 2, 2026 Sep 1, 2026 Aug 31, 2026 Aug 30, 2026 Aug 29, 2026 Aug 28, 2026 Aug 27, 2026 Aug 26, 2026 Aug 25, 2026 Aug 23, 2026 Aug 22, 2026 Aug 21, 2026 Aug 20, 2026 Aug 19, 2026 Aug 18, 2026 Aug 17, 2026 Aug 16, 2026 Aug 15, 2026 Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026

18 companies Today

Boost Run Inc. Class A Common Stock

BRUN Q2 2026

Reported: 2026-08-19

Boost Run’s stock was little changed, rising 0.4% after reporting a 270% year-over-year revenue increase and a $1.9 billion contracted revenue backlog; investors took a neutral view, reflecting confidence in growth alongside cautious scaling and capital intensity.

Key takeaways

Q2 revenue reached $31.1 million, up approximately 270% year-over-year and 260% sequentially.
Signed $1 billion in total contract value (TCV) during Q2, with a total backlog of $1.9 billion averaging 3 years and 22% prepayment.
Operates 6 data centers with 3 additional locations expected in the next 6 months, summing to 253 megawatts of capacity.
Continued investment in procurement, with a $1.44 billion Dell purchase agreement nearly fully allocated and active negotiations for an additional $4-5 billion in hardware.
Maintains operating discipline with SG&A at ~20% of revenue, well below peer levels, emphasizing a partner-driven model for data center access rather than ownership.

BlueScope Steel Limited

BSL.AX Q4 2026

Reported: 2026-08-19

Despite broadly stable operational execution, BlueScope's shares dropped 2.2% post-earnings, reflecting investor caution amid a cautious outlook for raw material spreads and continued headwinds in China weighing on margins and regional steel spreads.

Key takeaways

FY 2026 underlying EBIT reached $1.27 billion, materially higher than the prior year, driven by strong North American results and record Southeast Asian performance.
The company completed its initial $200 million cost reduction program and exceeded an additional $150 million cost-out target, contributing to a leaner cost base.
Major capital projects are moving from construction to ramp-up, including the Western Sydney metal coating line and New Zealand electric arc furnace, though both experienced delays and cost inflation.
FY 2027 first half guidance shows expected underlying EBIT of $860 million to $960 million, but is subject to risks from steel spread volatility, foreign exchange, and overcapacity in China.
The Board declared a $1.35 per share unfranked dividend, continuing return of capital after a prolonged investment phase.

Cogstate Limited

CGS.AX Q4 2026

Reported: 2026-08-19

Cogstate shares declined 2.5% post-earnings as investors appeared cautious despite solid revenue growth and expanding contracted sales, likely reflecting concerns over margin pressure and the company's cautious outlook on FY '27 revenue conversion.

Key takeaways

Revenue for FY '26 rose 15% to just under $61 million, with profit before tax increasing 16%; however, gross margins declined slightly from 61% to 58% over the year due to investments in ramping trial capacity.
Second half performance was notably stronger, with revenue up 27% versus first half and EBIT margins improving from 24% to 35%, indicating operating leverage benefit from higher volumes.
Contracted future revenue reached a record $118.5 million as of June 2026, up 54% year-over-year, providing good visibility into FY '27, though management emphasized that actual revenue growth depends on successful conversion of these contracts.
Trial starts nearly tripled to 90 in FY '26, with increased diversification across neurological areas beyond Alzheimer’s, supporting longer-term growth potential.
Despite strong top-line momentum and an active share buyback, margin compression and a cautious tone around contract conversion likely weighed on investor sentiment, limiting upside in the stock.

CSL Limited

CSLLY Q4 2026

Reported: 2026-08-19

The stock gained 16.5% following results that demonstrated encouraging early signs of stabilization and growth, notably from stronger second-half immunoglobulin demand and cost savings exceeding targets, which appear to have alleviated investor concerns about the prior period’s underperformance and cautious outlook.

Key takeaways

Revenue declined 1% to $15.8 billion, and underlying NPAT fell 3% to $2.8 billion, reflecting a reset year rather than a full recovery.
Immunoglobulin revenue was flat for the full year but grew 7% in the second half, indicating early positive impact from commercial investments in the U.S.
Seqirus revenue declined 8%, offset by 3% growth in Vifor; seasonal influenza vaccines showed resilience despite sector challenges.
Transformation program savings of $176 million exceeded expectations, with selective reinvestment ongoing to drive growth.
Cash flow remained strong at $3.5 billion, supporting a $1 billion share buyback and maintained dividends in USD, underscoring financial stability amid a turnaround phase.

Deterra Royalties Limited

DRR.AX Q4 2026

Reported: 2026-08-19

Shares rose modestly by 2.8% following FY26 results that reflected steady volume growth and ongoing debt reduction, but the restrained market response suggests investors remain cautious amid flat pricing and lack of clear catalysts beyond asset sales.

Key takeaways

NPAT of AUD 164 million driven by record MAC production/sales volume and profits from non-core precious metals asset sales.
Revenue and underlying EBITDA each increased 6%, supported by MAC royalties and record sales volume of 140 million dry metric tonnes (+9%).
Aussie dollar realized prices fell 2% due to FX headwinds despite a USD price increase.
Non-recurring items included lower MAC capacity payments and disposals from the Trident acquisition; AUD 108 million proceeds used to reduce debt.
Net debt reduced to AUD 132 million; balance sheet remains strong with AUD 357 million undrawn capacity and low all-in post-tax debt costs of 3.8%.

Erdene Resource Development Corporation

ERD.TO Q2 2026

Reported: 2026-08-19

The stock edged up slightly by 1.0% following Q2 results that showed operational improvements but lacked a clear catalyst to drive stronger market enthusiasm. Investors appear cautious, reflecting modest production gains and steady execution without a notable upside surprise.

Key takeaways

Bayan Khundii gold production increased 37% quarter-over-quarter to nearly 12,000 ounces, driven by a 25% improvement in ore feed grade to 2.4 g/t.
Plant throughput reached 94% of capacity with gold recoveries steady at 96%, above the 93% target.
Mining volumes increased 59% to 247,000 tonnes of ore, underpinned by enhanced mining techniques and equipment utilization.
Exploration efforts continue with a 12,000-meter drilling program approved for H2 2026 targeting resource expansion and mine life extension.
No change in guidance or updated outlook was provided, and broader project development milestones remain on track but unremarkable.

Fabrinet

FN Q4 2026

Reported: 2026-08-19

Fabrinet’s shares dropped 15.4% following the release, reflecting investor disappointment likely driven by cautious guidance or concerns about future growth despite strong reported quarterly results.

Key takeaways

Q4 revenue of $1.316 billion grew 45% year-over-year, exceeding the top end of guidance.
Non-GAAP EPS was $4.10, also above guidance, supported by operating leverage.
Management highlighted broad-based demand across multiple customers and markets, notably data centers and communications infrastructure.
Significant manufacturing capacity expansions were completed or underway, including facilities in Thailand and Silicon Valley.
Despite strong fiscal 26 results, the negative stock reaction suggests investors may be concerned about forward-looking commentary or potential deceleration risks not explicitly detailed in the transcript.

Geely Automobile Holdings Limited

GELYF Q2 2026

Reported: 2026-08-19

Geely's shares were little changed following earnings (+0.4%), reflecting a broadly in-line performance amid ongoing industry challenges including sales declines and cost pressures. While profitability remains above the industry average, growth momentum slowed in a tough Chinese auto market.

Key takeaways

First half 2026 revenue attributable to shareholders reached nearly CNY 10 billion with a profit margin of 5.6%, notably above the industry average of 1.6%.
Chinese auto market sales units declined double digits in H1 2026; chip and raw material cost inflation intensified competitive pressures.
Geely ranked #1 in domestic terminal sales per the Chinese Automobile Industry Association, supported by ongoing product intelligence upgrades and new energy powertrain development.
Export business has already achieved full-year targets with plans to diversify models and price points internationally, particularly targeting premium segments in Middle East and Europe.
Management emphasized strategic resilience and systematic capabilities as foundational for sustainable future growth despite geopolitical and market uncertainties.

HIVE Digital Technologies Ltd.

HIVE Q1 2027

Reported: 2026-08-19

HIVE Digital’s shares rose 3.3% as AI-related revenue growth and expanding GPU deployments appeared to offset ongoing macro headwinds and Bitcoin-related volatility, signaling modest investor optimism in the evolving business mix.

Key takeaways

AI revenue increased from approximately $1 million per month to $3 million, with expectations to reach $5–10 million monthly as new contracts ramp up.
Significant expansion in GPU-powered cash flow, driven primarily by NVIDIA chip deployments, underpinned the AI build-out strategy.
Hashing power scaled from 6 exahash to 25 exahash, providing economies of scale despite persistent headwinds from lower Bitcoin prices and rising mining difficulty.
Macro volatility remains a key risk factor, especially due to the Japan carry trade unwind and inflation-driven rate rises affecting global equity markets.
The company benefits from low-cost green energy operations across multiple geographies, supporting efficiency in both Bitcoin mining and HPC AI data centers.

Cypherpunk Holdings Inc.

HODL.CN Q3 2026

Reported: 2026-08-19

Shares fell 2.1% following the earnings release, reflecting cautious investor sentiment despite stable operational metrics and a promising pipeline. The market appears unimpressed by the limited immediate financial contribution from the newly acquired HoudiniSwap and the persistent noncash charges weighing on reported profitability.

Key takeaways

Revenue contribution from HoudiniSwap included only one month in the quarter, limiting its immediate impact despite management optimism on integration and future growth.
Approximately 80% of operating expenses were noncash, including nearly CAD 6 million in amortization/impairment and CAD 6.5 million in digital asset treasury revaluation, resulting in a CAD 1.1 million EBITDA loss after adjustments.
The digital asset treasury stood at CAD 48 million as of June 30, with a potential CAD 10 million uplift from a 20% increase in Sol price, highlighting sensitivity to crypto market volatility.
Validator business showed solid operational metrics with 100% uptime, 5.84% APY outperforming network average, and institutional validation via exclusive staking provider status for VanEck Solana ETF.
The STKESOL liquid staking token continued to grow, launched with over 500,000 Sol deposits, but impact on revenue or cash flow was not detailed.

Imdex Limited

IMD.AX Q4 2026

Reported: 2026-08-19

IMDEX's shares fell 4.2% following earnings as investors reacted to a cautious FY '27 outlook and margin pressure despite record FY '26 revenue and earnings. The negative market response suggests concerns over slowing growth or potential challenges ahead, which management did not fully address in the call.

Key takeaways

FY '26 revenue increased 21% to $520 million, driven by broad-based regional growth and market share gains.
Normalized EBITDA rose 29% to $163 million, with margins expanding to just over 31%, despite rising costs and FX headwinds.
Net debt increased to $199 million due to five acquisitions, pushing leverage to 1.3x but remaining within target range.
Cash conversion remained strong at 83%, supporting continued investment and a 36% increase in full-year dividend to $0.034 per share.
Management highlighted transformation into an integrated physical-to-digital platform, yet the outlook implied caution, which likely contributed to the stock decline.

Kuya Silver Corporation

KUYA.CN Q2 2026

Reported: 2026-08-19

Shares declined 7.5% as investors reacted negatively to a cautious outlook masked by early-stage ramp-up challenges, capital-intensive development costs, and no clear timeline for achieving steady-state production. Margins remain under pressure, and revenue gains have yet to translate into profitability.

Key takeaways

Q2 silver equivalent production reached a quarterly record of 30,500 ounces, representing a significant increase supported by a 66% rise in mined tonnage from Q1.
Revenue for Q2 was roughly $1.25 million, more than doubling the first half of 2025 results to $2.7 million year-to-date.
Net loss widened to approximately $2.8 million for the first six months of 2026, driven by intensified development activities and higher operational costs.
Underground development advanced 437 meters, enabling future production capacity, but development remains capital intensive and a drag on near-term profitability.
Management reiterated a target of ramping to 350 tonnes per day by year-end but did not provide a firm timeline, highlighting ongoing uncertainties in operations and expansion phases.

Kuya Silver Corporation

KUYAF Q2 2026

Reported: 2026-08-19

Kuya Silver’s shares fell 7.7% following the earnings release, reflecting investor disappointment with the cautious outlook on production ramp-up and ongoing capital-intensive development weighing on margins and near-term profitability.

Key takeaways

Q2 production at Bethania surged with mineralized material mined up 66% from Q1 and a record 30,500 silver equivalent ounces processed.
Average silver grade improved to 6.66 oz/tonne and recovery reached ~82%, highlighting operational progress despite early-stage status.
Revenue increased to $1.25 million for the quarter, more than doubling H1 2026 revenue versus last year, yet the company remains unprofitable with a $2.8 million net loss for the first half.
Capital spending and development activities intensified, including 437 meters of underground advancement and infrastructure upgrades, pressuring margins.
Management signaled a targeted throughput of 350 tonnes per day by year-end, but timing remains uncertain, underscoring execution risk and a cautious outlook.

Lark Distilling Co. Ltd

LRK.AX Q4 2026

Reported: 2026-08-19

Shares of LARK declined 3.4% following the earnings release, reflecting investor concerns primarily around ongoing operating losses and cautious near-term profitability despite solid revenue growth and positive brand momentum.

Key takeaways

Net sales increased 15% to $18 million, demonstrating solid topline growth amid challenging market conditions.
Operating EBITDA loss widened to $4.5 million, driven by continued upfront investments in marketing and commercial capabilities.
Inventory and goodwill impairments were made to clean up the balance sheet, signaling cautious financial housekeeping ahead of FY '27.
Cash position remains strong at approximately $14.3 million with zero debt, supporting growth ambitions.
International channels, particularly Global Travel Retail and international markets, delivered strong growth of 43% and 69% respectively, bolstered by recent product relaunch and award recognitions.

Mercury NZ Limited

MCY.NZ Q4 2026

Reported: 2026-08-19

Mercury’s shares rose 4.8% as the company delivered EBITDAF growth driven by higher renewable generation and disciplined cost management, while reaffirming ambitious investment and dividend targets.

Key takeaways

EBITDAF increased 36% to $1.068 billion, powered by a 15% rise in total generation to 9.1 terawatt hours, supported by hydro, geothermal, and new wind projects.
Operating expenses were tightly controlled at $370 million, down $26 million from FY ’25, reflecting structural efficiencies in people and maintenance costs.
Capital expenditure rose 46% to $710 million, with a focus on growth projects and asset refurbishment, including a $590 million hydro refurbishment program and commitment to geothermal drilling.
The dividend was increased 13% to $0.27 per share, with guidance indicating a further rise to $0.29 for FY ’27; the company is reviewing dividend policy post its current investment cycle.
Balance sheet remains solid with debt/EBITDAF at approximately 2.0x, comfortably within BBB rating guardrails despite record investments.

NRx Pharmaceuticals, Inc.

NRXP Q2 2026

Reported: 2026-08-19

NRx Pharmaceuticals shares rose 5.2% following Q2 results, driven by significant progress toward regulatory approvals and a promising federally backed clinical trial partnership that expands the potential market for NRX-101.

Key takeaways

Completed first FDA review cycle for preservative-free ketamine ANDA with only one minor manufacturing-related deficiency remaining, targeting approval in 2026.
Advanced NRX-100 NDA with strong external alignment, supported by White House and Congressional guidance endorsing real-world evidence for psychedelic depression treatments; aiming for 2027 approval.
Secured a prime contractor role with DARPA for the SPARC-TMS trial of NRX-101 combined with robotic TMS, potentially opening a large new market in military and first responder mental health.
Expanded HOPE Therapeutics clinical footprint in Florida, supporting growth ambitions.
Ordered 5 million units of launch stock for preservative-free ketamine, reflecting confidence in upcoming commercial readiness.

New Era Helium Inc Common Stock

NUAI Q2 2026

Reported: 2026-08-19

Shares rose modestly by 1.2% following a quarter marked by operational progress on permitting and site preparation, balanced against continued cautious advancement on commercial and power agreements. The market appears to have taken a neutral view, recognizing execution milestones but awaiting clearer commercial traction and final power contracts.

Key takeaways

Construction permits secured for TCDC site, reducing development risk ahead of imminent site grading.
Combined gross capacity for Phases 1 and 2 is approximately 757 megawatts, supported by filed air permits for Phase 2.
Power Purchase Agreement (PPA) negotiations advancing, with company stepping in to finalize the Phase 1 power arrangement in its own name.
Strong balance sheet with $84.8 million cash on hand and $270 million undrawn credit facility, sufficient to cover Phase 1 equity needs.
Significant leadership additions with deep data center and energy infrastructure expertise, underscoring focus on execution capability.

Sol Strategies Inc. Common Shares

STKE Q3 2026

Reported: 2026-08-19

Shares declined 1.9% following the quarter as investors digested modest EBITDA losses and high noncash expenses, tempered by early-stage contribution from the Houdini acquisition. The market appeared unimpressed by the cautious near-term outlook implied by incremental progress rather than step-change growth.

Key takeaways

EBITDA loss was CAD 1.1 million after stripping out over 80% of operating expenses tied to noncash items including CAD 6 million intangible asset amortization and CAD 6.5 million digital treasury revaluation.
HoudiniSwap contributed only one month of revenue within the quarter, limiting its financial impact despite management’s positive outlook for future quarters.
The Solana treasury remained substantial at CAD 48 million, representing a key balance sheet asset with potential upside from favorable Sol price moves.
Validator business maintained 100% uptime and slightly outperformed network APY averages at 5.84%, also securing the VanEck Solana ETF staking contract—providing some operational stability.
Transaction fees and MEV commissions remain core revenue drivers, but the company’s results reflect ongoing integration and expansion risks rather than accelerated growth.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.